Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme
β Scribed by Petra Nowotny; Anthony L. Hinrichs; Scott Smemo; John S.K. Kauwe; Taylor Maxwell; Peter Holmans; Marian Hamshere; Dragana Turic; Luke Jehu; Paul Hollingworth; Pamela Moore; Leslie Bryden; Amanda Myers; Lisa M. Doil; Kristina M. Tacey; Alison M. Gibson; Ian G. McKeith; Robert H. Perry; Chris M. Morris; Leon Thal; John C. Morris; Michael C. O'Donovan; Simon Lovestone; Andrew Grupe; John Hardy; Michael J. Owen; Julie Williams; Alison Goate
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 161 KB
- Volume
- 136B
- Category
- Article
- ISSN
- 1552-4841
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Linkage studies have suggested a susceptibility locus for lateβonset Alzheimer's disease (LOAD) on chromosome 21. A functional candidate gene in this region is the Ξ²βamyloid precursor protein (APP) gene. Previously, coding mutations in APP have been associated with early onset Alzheimer
Butyrylcholinesterase (BChE) as well as acetylcholinesterase has been suggested to be associated with Alzheimer's disease (AD). : Hum Mol Genet 6: 1933-1936] recently reported the synergism between the gene for the K variant of BChE (BCHE-K) and the 4 allele of apolipoprotein E (APOE 4) in late-onse
It is now commonly known that possession of one of the three common alleles of the apolipoprotein E (APOE) gene (allele epsilon 4) confers an increased risk for both familial and sporadic Alzheimer's disease (AD), and that this risk is dose-dependent. Other genes that may play a role in AD, either t